Abstract
This report presents the experience with single and combination chemotherapy in the Noble rat prostatic adenocarcinoma model. The best single agent in treatment of these tumors is cyclophosphamide, the best combination was triple drug therapy cyclophosphamide, cis-platinum, and adriamycin. This report examines the effect of the various chemotherapeutic regimens on tumor volume, number of metastases, and complete tumor regression.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 353-363 |
| Number of pages | 11 |
| Journal | Journal of Surgical Oncology |
| Volume | 16 |
| Issue number | 4 |
| State | Published - 1981 |
ASJC Scopus subject areas
- Oncology
- Surgery
Fingerprint Dive into the research topics of 'Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model'. Together they form a unique fingerprint.
Cite this
Drago, J. R., Worgul, T., & Gershwin, M. E. (1981). Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model. Journal of Surgical Oncology, 16(4), 353-363.